Neurocrine Biosciences

NASDAQ
NBIX
Stock
Yield per half year: -17.98%
Dividend yield: 0%
Sector: Healthcare

125.01 $

0 $ 0%
87.54 $
153.29 $

Min/max per year

Share chart Neurocrine Biosciences

About Neurocrine Biosciences

Neurocrine Biosciences является публичной биофармацевтической компанией, основанной в 1992 году. Головной офис компании находится в Сан-Диего, штат Калифорния, и возглавляет генеральный директор Кевин Горман. Нейрокрин разрабатывает методы лечения неврологических и эндокринных заболеваний и расстройств.

Main settings

IPO date
1996-05-23
ISIN
US64125C1099
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
0
Сайт

Grade

Underestimation
Title Value Grade
P/S 6.03 1
P/BV 5.49 2
P/E 41.64 4
Efficiency
Title Value Grade
ROA 9.79 3
ROE 14.16 4
ROIC 5.01 2
Dividends
Title Value Grade
Dividend yield 0 0
DSI 0 0
Average dividend growth 0 0
Debt
Title Value Grade
Debt/EBITDA 0.7114 9
Debt/Ratio 0.1224 10
Debt/Equity 0.436 10
Growth impulse
Title Value Grade
Yield Revenue, % 124.31 10
Yield Ebitda, % 95.33 9
Yield EPS, % -20.88 0

Prices

Price Min. Max. Change Changes in the industry Changes in the index
Yesterday 125.01 $ 0 $ 0 $ 0 % 0 % 0 %
Week 125.39 $ 0 $ 0 $ -0.3031 % 0 % 0 %
Month 119.12 $ 0 $ 0 $ +4.94 % 0 % 0 %
Three month 95.28 $ 100.68 $ 125.73 $ +31.2 % 0 % 0 %
Half a year 152.42 $ 87.54 $ 153.29 $ -17.98 % 0 % 0 %
Year 152.55 $ 87.54 $ 153.29 $ -18.05 % 0 % 0 %
3 years 102.87 $ 87.54 $ 153.29 $ +21.52 % 0 % 0 %
5 years 107.91 $ 73.55 $ 153.29 $ +15.85 % 0 % 0 %
10 years 42.65 $ 32.19 $ 153.29 $ +193.11 % 0 % 0 %
Year to date 146.76 $ 87.54 $ 153.29 $ -14.82 % 0 % 0 %

Insider trading

Main owners

Contained in ETF

ETF
Share, %
Profitability for 1 year, %
Commission, %
PSYK ETF 4.51 0 0.75
VictoryShares Nasdaq Next 50 ETF 1.2271 4.94 0.18
Future Tech ETF 1.15959 479.5 0.35
Principal Healthcare Innovators ETF 1.15959 -3.92 0.35
GraniteShares XOUT U.S. Large Cap ETF 0.80826 -24.16 0.60
First Trust Mid Cap US Equity Select ETF 0.787 -4.33 0.60
Donoghue Forlines Innovation ETF 0.55247 20.73 0.69
Syntax Stratified MidCap ETF 0.36602 -0.3413 0.35
FCF US Quality ETF 0.29911 9.04 0.59
iShares Morningstar Mid-Cap Growth ETF 0.22135 450.65 0.06
iShares Morningstar Mid-Cap ETF 0.1109 245.03 0.04
iShares Morningstar Large-Cap Growth ETF 0.04883 245.22 0.04
iShares Factors US Growth Style ETF 0.03532 -6.31 0.25
Columbia U.S. ESG Equity Income ETF 0.02679 -4.51 0.35
iShares Morningstar Large-Cap ETF 0.02418 186.3 0.03
0.76106.520.35

Similar companies



Company management

Head Job title Payment Year of birth
Mr. Matthew C. Abernethy Chief Financial Officer 1.04M 1980 (45 years)
Mr. Eric S. Benevich Chief Commercial Officer 805k 1965 (60 years)
Jane Sorensen Head of Investor Relations N/A
Ms. Julie S. Cooke Chief Human Resources Officer N/A 1966 (59 years)
Dr. Kevin C. Gorman Ph.D. CEO & Director 1.9M 1958 (67 years)
Dr. Jude Onyia Ph.D. Chief Scientific Officer 621.66k 1964 (61 year)
Dr. Eiry Wyn Roberts M.D. Chief Medical Officer 1.04M 1964 (61 year)
Mr. Darin M. Lippoldt Esq. Chief Legal Officer & Corporate Secretary 921.01k 1966 (59 years)
Mr. Kyle W. Gano Ph.D. Chief Business Development & Strategy Officer 921.52k 1973 (52 years)
Mr. David Warren Boyer Chief Corporate Affairs Officer N/A 1980 (45 years)

About company

Address: United States, San Diego, 12780 El Camino Real - Open in google maps, Open in yandex maps
Website: http://www.neurocrine.com